Sofgen Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar '26 Mar 5, 2026	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Jan '20 Jan 1, 2020
Market Capitalization	56	459	592	1,100	260	240
Market Cap Growth	-83.02%	-22.48%	-46.15%	323.09%	8.29%	-
Enterprise Value	350	731	818	1,220	-	-
Last Close Price	0.02	4.07	5.25	9.75	10.40	9.85
PE Ratio	0.06	11.38	16.40	-	-	-
Forward PE	-	14.09	12.21	-	-	-
PS Ratio	0.13	1.08	1.47	2.73	0.78	0.74
PB Ratio	-75.75	-623.90	-15.95	-15.72	-1.02	-0.98
P/FCF Ratio	0.64	5.26	-	54.96	4.11	4.25
P/OCF Ratio	0.52	4.27	38.09	31.03	3.67	3.52
PEG Ratio	-	0.32	0.29	-	-	-
EV/Sales Ratio	0.83	1.72	2.03	3.02	-	-
EV/EBITDA Ratio	4.61	10.48	19.49	669.77	-	-
EV/EBIT Ratio	5.71	11.93	23.98	-	-	-
EV/FCF Ratio	4.01	8.37	-	60.93	-	-
Debt / Equity Ratio	-424.80	-424.80	-8.09	-3.62	-1.78	-1.72
Debt / EBITDA Ratio	4.12	4.12	6.23	41.92	5.71	7.80
Debt / FCF Ratio	3.58	3.58	-	12.66	7.19	7.44
Net Debt / Equity Ratio	-401.00	-401.00	-6.93	-2.59	-1.77	-1.71
Net Debt / EBITDA Ratio	4.23	4.23	6.13	99.54	6.01	8.58
Net Debt / FCF Ratio	3.38	3.38	-33.81	9.06	7.12	7.41
Asset Turnover	0.93	0.93	0.90	1.00	0.95	-
Inventory Turnover	1.84	1.84	1.86	2.39	2.17	-
Quick Ratio	0.39	0.39	0.42	0.55	0.47	0.43
Current Ratio	0.69	0.69	0.72	0.80	0.77	0.69
Return on Assets (ROA)	8.37%	8.37%	4.78%	-1.40%	11.30%	-
Return on Invested Capital (ROIC)	17.76%	20.90%	15.58%	-5.91%	-419.33%	21.46%
Return on Capital Employed (ROCE)	86.40%	86.40%	60.70%	-9.60%	52.60%	41.90%
Earnings Yield	72.36%	8.79%	6.10%	-9.73%	-4.02%	-7.08%
FCF Yield	156.59%	19.01%	-1.28%	1.82%	24.32%	23.53%
Buyback Yield / Dilution	0.10%	0.10%	-3.02%	-1.04%	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.